Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Pain Management Knowledge and Attitudes of Healthcare Professionals in Primary Medical Centers.

Alkhatib GS, Al Qadire M, Alshraideh JA.

Pain Manag Nurs. 2019 Sep 25. pii: S1524-9042(18)30387-4. doi: 10.1016/j.pmn.2019.08.008. [Epub ahead of print]

PMID:
31563514
2.

Low levels of HIV-1 envelope-mediated fusion are associated with long-term survival of an infected CCR5-/- patient.

Gorry PR, Ahmad F, Mohl J, Alkhatib G.

AIDS. 2018 Oct 23;32(16):2269-2278. doi: 10.1097/QAD.0000000000001953.

3.

Role for the conserved N-terminal cysteines in the anti-chemokine activities by the chemokine-like protein MC148R1 encoded by Molluscum contagiosum virus.

Jin Q, Altenburg JD, Hossain MM, Alkhatib G.

Virology. 2011 Sep 1;417(2):449-56. doi: 10.1016/j.virol.2011.07.001. Epub 2011 Jul 28.

4.

The potent anti-HIV activity of CXCL12gamma correlates with efficient CXCR4 binding and internalization.

Altenburg JD, Jin Q, Alkhatib B, Alkhatib G.

J Virol. 2010 Mar;84(5):2563-72. doi: 10.1128/JVI.00342-09. Epub 2009 Dec 16.

5.

Alternate receptor usage of neuropilin-1 and glucose transporter protein 1 by the human T cell leukemia virus type 1.

Jin Q, Alkhatib B, Cornetta K, Alkhatib G.

Virology. 2010 Jan 20;396(2):203-12. doi: 10.1016/j.virol.2009.10.015. Epub 2009 Nov 13.

6.

The biology of CCR5 and CXCR4.

Alkhatib G.

Curr Opin HIV AIDS. 2009 Mar;4(2):96-103. doi: 10.1097/COH.0b013e328324bbec. Review.

7.

Counterpoint: Cord blood stem cell therapy for acquired immune deficiency syndrome.

Alkhatib G.

Stem Cells Dev. 2009 Jan-Feb;18(1):5-6. doi: 10.1089/scd.2008.0304.cp2. No abstract available.

8.
9.

CCR5Delta32 59537-G/A promoter polymorphism is associated with low translational efficiency and the loss of CCR5Delta32 protective effects.

Jin Q, Agrawal L, Meyer L, Tubiana R, Theodorou I, Alkhatib G.

J Virol. 2008 Mar;82(5):2418-26. Epub 2007 Dec 19.

10.

HIV gp120 interactions with coreceptors: insights from studies with CCR5-based peptides.

Berger EA, Alkhatib G.

Eur J Med Res. 2007 Oct 15;12(9):403-7. Review.

PMID:
17933721
11.

HIV coreceptors: from discovery and designation to new paradigms and promise.

Alkhatib G, Berger EA.

Eur J Med Res. 2007 Oct 15;12(9):375-84. Review.

PMID:
17933717
12.

CCR5Delta32 protein expression and stability are critical for resistance to human immunodeficiency virus type 1 in vivo.

Agrawal L, Jin Q, Altenburg J, Meyer L, Tubiana R, Theodorou I, Alkhatib G.

J Virol. 2007 Aug;81(15):8041-9. Epub 2007 May 23.

13.
14.

Anti-HIV therapy: Current and future directions.

Agrawal L, Lu X, Jin Q, Alkhatib G.

Curr Pharm Des. 2006;12(16):2031-55. Review.

PMID:
16787246
15.

GLUT-1-independent infection of the glioblastoma/astroglioma U87 cells by the human T cell leukemia virus type 1.

Jin Q, Agrawal L, Vanhorn-Ali Z, Alkhatib G.

Virology. 2006 Sep 15;353(1):99-110. Epub 2006 Jun 16.

17.

Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells.

Agrawal L, Lu X, Qingwen J, VanHorn-Ali Z, Nicolescu IV, McDermott DH, Murphy PM, Alkhatib G.

J Virol. 2004 Mar;78(5):2277-87.

18.

Specific inhibition of HIV-1 coreceptor activity by synthetic peptides corresponding to the predicted extracellular loops of CCR5.

Agrawal L, VanHorn-Ali Z, Berger EA, Alkhatib G.

Blood. 2004 Feb 15;103(4):1211-7. Epub 2003 Oct 23.

PMID:
14576050
19.

Chemokine receptors: emerging opportunities for new anti-HIV therapies.

Agrawal L, Alkhatib G, Agrawal L.

Expert Opin Ther Targets. 2001 Jun;5(3):303-326.

PMID:
12540267
20.
21.

The seventh transmembrane domain of cc chemokine receptor 5 is critical for MIP-1beta binding and receptor activation: role of MET 287.

Youn BS, Yu KY, Alkhatib G, Kwon BS.

Biochem Biophys Res Commun. 2001 Mar 2;281(3):627-33.

PMID:
11237703
22.

CC chemokine receptors 1 and 3 are differentially regulated by IL-5 during maturation of eosinophilic HL-60 cells.

Tiffany HL, Alkhatib G, Combadiere C, Berger EA, Murphy PM.

J Immunol. 1998 Feb 1;160(3):1385-92.

23.
25.
27.
28.

A new SIV co-receptor, STRL33.

Alkhatib G, Liao F, Berger EA, Farber JM, Peden KW.

Nature. 1997 Jul 17;388(6639):238. No abstract available.

PMID:
9230431
29.

STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1.

Liao F, Alkhatib G, Peden KW, Sharma G, Berger EA, Farber JM.

J Exp Med. 1997 Jun 2;185(11):2015-23.

30.

Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk.

Zimmerman PA, Buckler-White A, Alkhatib G, Spalding T, Kubofcik J, Combadiere C, Weissman D, Cohen O, Rubbert A, Lam G, Vaccarezza M, Kennedy PE, Kumaraswami V, Giorgi JV, Detels R, Hunter J, Chopek M, Berger EA, Fauci AS, Nutman TB, Murphy PM.

Mol Med. 1997 Jan;3(1):23-36.

32.

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.

Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA.

Science. 1996 Jun 28;272(5270):1955-8.

PMID:
8658171
33.

Characterization of a cleavage mutant of the measles virus fusion protein defective in syncytium formation.

Alkhatib G, Roder J, Richardson C, Briedis D, Weinberg R, Smith D, Taylor J, Paoletti E, Shen SH.

J Virol. 1994 Oct;68(10):6770-4.

34.

Functional analysis of N-linked glycosylation mutants of the measles virus fusion protein synthesized by recombinant vaccinia virus vectors.

Alkhatib G, Shen SH, Briedis D, Richardson C, Massie B, Weinberg R, Smith D, Taylor J, Paoletti E, Roder J.

J Virol. 1994 Mar;68(3):1522-31.

35.

Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins.

Taylor J, Weinberg R, Tartaglia J, Richardson C, Alkhatib G, Briedis D, Appel M, Norton E, Paoletti E.

Virology. 1992 Mar;187(1):321-8.

PMID:
1736535
36.

Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge.

Taylor J, Pincus S, Tartaglia J, Richardson C, Alkhatib G, Briedis D, Appel M, Norton E, Paoletti E.

J Virol. 1991 Aug;65(8):4263-74.

38.

Synthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirus vector containing the beta-galactosidase gene.

Vialard J, Lalumière M, Vernet T, Briedis D, Alkhatib G, Henning D, Levin D, Richardson C.

J Virol. 1990 Jan;64(1):37-50.

41.

The predicted primary structure of the measles virus hemagglutinin.

Alkhatib G, Briedis DJ.

Virology. 1986 Apr 30;150(2):479-90.

PMID:
3008420

Supplemental Content

Loading ...
Support Center